Could An Anti-Cancer Cream Replace Anti-Aging Lasers?

Could An Anti-Cancer Cream Replace Anti-Aging Lasers? featured image

It’s been around for almost half a century, but it’s the new anti-aging cream on the block. Fluorouracil, which was originally used as an intravenous chemotherapy drug, has evolved into a topical treatment for precancerous actinic keratosis lesions. But as researchers have recently found, its potential isn’t limited to cancer care.

In a University of Michigan Medical School study, patients with actinic keratoses applied a 5% fluorouracil cream, also known by brand names Efudex and Fluoroplex, to their faces twice a day for two weeks. Not only did this treatment reduce the average number of lesions from more than 11 to less than two, but it also followed “a wound-healing pattern of events reminiscent of that seen with laser treatment of photo-aging,” according to the Archives of Dermatology report. The results included a decrease in fine lines, wrinkles, hyperpigmentation (such as age spots), and sallowness.

“For patients in whom a course of topical fluorouracil is indicated for the treatment of actinic keratoses, there will likely be the additional benefit of a restorative effect from sun damage,” the researchers wrote. “Undoubtedly, there will be patients who desire a therapy such as topical fluorouracil for cosmetic purposes given the relatively low cost of this therapy compared with ablative laser resurfacing.”

Fluorouracil, which works by disrupting a DNA-replicating enzyme, is not currently FDA-approved for cosmetic use. However, that could change in the relatively near future if additional research, trials and doctor-prescribed off-label use prove its benefits are greater than the possible side effects.

Related Posts

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.